EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Engineering Saccharomyces cerevisiae for the de novo Production of Halogenated Tryptophan and Tryptamine Derivatives

Nicholas Milne, Javier Sáez-Sáez, Annette Munch Nielsen, Jane Dannow Dyekjaer, Daniela Rago, Mette Kristensen, Tune Wulff, Irina Borodina iD

ChemistryOpen · 2023

DOI: 10.1002/open.202200266 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ChemistryOpen, 2023. Verfasst von Nicholas Milne und 7 weiteren Autor:innen. Beteiligte Einrichtung: The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark. Hauptthemen laut MEDLINE: Saccharomyces cerevisiae, Biological Products. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 109 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Commission, Novo Nordisk Fonden, European Research Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The indole scaffold is a recurring structure in multiple bioactive heterocycles and natural products. Substituted indoles like the amino acid tryptophan serve as a precursor for a wide range of natural products with pharmaceutical or agrochemical applications. Inspired by the versatility of these compounds, medicinal chemists have for decades exploited indole as a core structure in the drug discovery process. With the aim of tuning the properties of lead drug candidates, regioselective halogenation of the indole scaffold is a common strategy. However, chemical halogenation is generally expensive, has a poor atom economy, lacks regioselectivity, and generates hazardous waste streams. As an alternative, in this work we engineer the industrial workhorse Saccharomyces cerevisiae for the de novo production of halogenated tryptophan and tryptamine derivatives. Functional expression of bacterial tryptophan halogenases together with a partner flavin reductase and a tryptophan decarboxylase resulted in the production of halogenated tryptophan and tryptamine with chlorine or bromine. Furthermore, by combining tryptophan halogenases, production of di‐halogenated molecules was also achieved. Overall, this works paves the road for the production of new‐to‐nature halogenated natural products in yeast.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Saccharomyces cerevisiaeBiological ProductsTryptophanTryptamines

Stichwörter der Autor:innen

Saccharomyces cerevisiaehalogenasesindolein vivo halogenationmetabolic engineering

Substanzen

TryptophantryptamineTryptaminesBiological Products

Autor:innen und Institutionen

  • The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark, 2800, Kgs. Lyngby, Denmark.
  • Octarine Bio ApS, Lersø Parkallé 42, 1. Sal, 2100, Copenhagen, Denmark.

ORCID-Profile: Irina Borodina

Förderung

  • European Commission
  • Novo Nordisk Fonden
  • European Research Council

Zitieren

APA

Milne, N., Sáez-Sáez, J., Nielsen, A. M., Dyekjaer, J. D., Rago, D., Kristensen, M., Wulff, T., & Borodina, I. (2023). Engineering Saccharomyces cerevisiae for the de novo Production of Halogenated Tryptophan and Tryptamine Derivatives. ChemistryOpen. https://doi.org/10.1002/open.202200266

Vancouver

Milne N, Sáez-Sáez J, Nielsen AM, Dyekjaer JD, Rago D, Kristensen M, et al. Engineering Saccharomyces cerevisiae for the de novo Production of Halogenated Tryptophan and Tryptamine Derivatives. ChemistryOpen. 2023. doi:10.1002/open.202200266

BibTeX
@article{Milne2023,
  author = {Milne, Nicholas and Sáez-Sáez, Javier and Nielsen, Annette Munch and Dyekjaer, Jane Dannow and Rago, Daniela and Kristensen, Mette and Wulff, Tune and Borodina, Irina},
  title = {Engineering Saccharomyces cerevisiae for the de novo Production of Halogenated Tryptophan and Tryptamine Derivatives},
  journal = {ChemistryOpen},
  year = {2023},
  doi = {10.1002/open.202200266}
}
Kostenlos starten →